Steep Hill (XCNQ:STPH) EBIT : C$-0.46 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Steep Hill EBIT?

Steep Hill's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was C$-0.02 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.46 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Steep Hill's annualized ROC % for the quarter that ended in Dec. 2023 was -21.75%. Steep Hill's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -352.94%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Steep Hill's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 21.91%.

Steep Hill EBIT Historical Data

The historical data trend for Steep Hill's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steep Hill EBIT Chart

Steep Hill Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

-0.48

-2.09

-4.49

-4.23

-0.46

Steep Hill Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT	Get a 7-Day Free Trial													-3.03	-0.14	-0.24	-0.07	-0.02

Competitive Comparison of Steep Hill's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Steep Hill's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Steep Hill's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Steep Hill's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Steep Hill's EV-to-EBIT falls into.

Steep Hill EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.46 Mil.

Steep Hill (XCNQ:STPH) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Steep Hill's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	-0.188 * ( 1 - 0% )	/	( (1.695	+	0.034)	/ 2 )
=	-0.188	/	0.8645
=	-21.75 %

where

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	3.634	-	0.333	-	( 3.177	-	max(0, 2.009	-	3.615	+	3.177	))
=	1.695

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2.757	-	1.087	-	( 2.613	-	max(0, 1.106	-	2.742	+	2.613	))
=	0.034

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Steep Hill's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-0.06	/	( ( (0.019 + max(-1.559, 0))	+	(0.015 + max(-1.043, 0)) )	/	2 )
=	-0.06	/	( ( 0.019	+	0.015 )	/	2 )
=	-0.06	/	0.017
=	-352.94 %

where Working Capital is:

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.034	+	0	+	0.356)	-	(0.333	+	0	+	1.616)
=	-1.559

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0.044)	-	(1.087	+	0	+	2.2204460492503E-16)
=	-1.043

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Steep Hill's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	-0.462	/	-2.109
	=	21.91 %

Steep Hill EBIT Related Terms

Thank you for viewing the detailed overview of Steep Hill's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Steep Hill (XCNQ:STPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Steep Hill Inc (XCNQ:STPH) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

120 Adelaide Street West, Suite 2500, Toronto, ON, CAN, M5H 1T1

Website

https://www.steephill.com

Steep Hill Inc is a science and technology health and wellness company focused on the hemp markets inclusive of plant-based, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) verticals. Currently the company, through its subsidiaries holds three industrial hemp licences for the purposes of supplying the global market with medicinal and wellness cannabidiol and other cannabinoid-based products.

Steep Hill (XCNQ:STPH) Headlines

No Headlines